Grail

(NASDAQ) GRAL

Current Price$62.91

Market Cap$2.58B

Since IPO (2024)+359%

5 YearN/A

1 Year+81%

1 Month+28%

Grail Financials at a Glance

Market Cap

$2.58B

Revenue (TTM)

$156.12M

Net Income (TTM)

$395.32M

EPS (TTM)

$-10.38

P/E Ratio

-6.06

Dividend

$0.00

Beta (Volatility)

2.39 (High)

Dividend

$0.00

Beta (Volatility)

2.39 (High)

Price

$62.91

Volume

1,786

Open

$63.50

Price

$62.91

Volume

1,786

Open

$63.50

Previous Close

$62.92

Daily Range

$61.04 - $64.68

52-Week Range

$29.95 - $118.84

Dividend

$0.00

Beta (Volatility)

2.39 (High)

Price

$62.91

Volume

1,786

Open

$63.50

Previous Close

$62.92

Daily Range

$61.04 - $64.68

52-Week Range

$29.95 - $118.84

GRAL News

relaxed investor watching stocks analyst-1200x800-5b2df79 (1)

Here's Why Grail Stock Soared Higher This Week

Lee SamahaMar 26, 2026

This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month

Jonathan PoncianoMar 22, 2026

Here's Why Grail Shares Crushed the Market This Week

Lee SamahaMar 21, 2026

Here's Why Grail Shares Crashed in February and Why it Could Be a Buying Opportunity

Lee SamahaMar 11, 2026

Here's Why Grail Stock Bounced Back 16% Today

Lee SamahaFeb 24, 2026

Why Grail Shares Are Plummeting

Matthew BenjaminFeb 23, 2026

Here's Why Grail Stock Slumped Again Today

Lee SamahaFeb 23, 2026

This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50%

Jonathan PoncianoFeb 23, 2026

Page 1

GRAL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Grail

Industry

Biotechnology

Sector

Health Care

Employees

910

CEO

Robert P. Ragusa, MBA

Website

www.grail.com

Headquarters

Menlo Park, CA 94025, US

GRAL Financials

Key Financial Metrics (TTM)

Gross Margin

-15%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

-16%

Return on Capital

-20%

Return on Assets

-14%

Earnings Yield

-16.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.58B

Shares Outstanding

41.02M

Volume

1.79K

Avg. Volume

1.25M

Financials (TTM)

Gross Profit

$62.57M

Operating Income

$534.16M

EBITDA

$377.82M

Operating Cash Flow

$299.01M

Capital Expenditure

$909.00K

Free Cash Flow

$299.01M

Cash & ST Invst.

$904.43M

Total Debt

$98.01M

Grail Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$40.78M

+28.1%

Gross Profit

$19.54M

+198.1%

Gross Margin

47.91%

N/A

Market Cap

$2.58B

N/A

Market Cap/Employee

$2.58M

N/A

Employees

1,000

N/A

Net Income

$93.19M

+12.3%

EBITDA

$135.76M

-18.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$772.08M

+26.5%

Accounts Receivable

$20.34M

+5.0%

Inventory

$0.00

-100.0%

Long Term Debt

$41.09M

-20.0%

Short Term Debt

$9.94M

-23.4%

Return on Assets

-14.10%

N/A

Return on Invested Capital

-19.95%

N/A

Free Cash Flow

$87.49M

+8.0%

Operating Cash Flow

$86.99M

+8.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RAREUltragenyx Pharmaceutical Inc.

RAREUltragenyx Pharmaceutical Inc.$26.13+0.77%

IDYAIDEAYA Biosciences, Inc.

IDYAIDEAYA Biosciences, Inc.$28.24-1.74%

SLNOSoleno Therapeutics, Inc.

SLNOSoleno Therapeutics, Inc.$52.95+0.02%

DYNDyne Therapeutics, Inc.

DYNDyne Therapeutics, Inc.$17.54-6.90%

AAPGAscentage Pharma Group International

AAPGAscentage Pharma Group International$21.70+0.60%

NVSTEnvista Holdings Corp

NVSTEnvista Holdings Corp$24.29-10.27%

XENEXenon Pharmaceuticals Inc.

XENEXenon Pharmaceuticals Inc.$56.00-4.42%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$12.34-0.06%

NVDANvidia

NVDANvidia$211.56+0.02%

INTCIntel

INTCIntel$109.59-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

TSLATesla

TSLATesla$411.25+0.03%

SMCISuper Micro Computer

SMCISuper Micro Computer$33.55-0.03%

AAPLApple

AAPLApple$287.40-0.00%

Questions About GRAL

What is the current price of Grail?

Grail is trading at $62.92 per share.

What is the 52-week range for Grail?

Over the past 52 weeks, Grail has traded between $29.95 and $118.84.

How much debt does Grail have?

As of the most recent reporting period, Grail reported total debt of $51.03M.

How much cash does Grail have on hand?

Grail reported $69.34M in cash and cash equivalents in its most recent financial results.

What is Grail’s dividend yield?

Grail does not currently have a dividend yield.

Grail

Grail Financials at a Glance

GRAL News

Here's Why Grail Stock Soared Higher This Week

This Investor Exited a $22 Million GRAIL Stake Before a 50% One-Day Stock Crash Last Month

Here's Why Grail Shares Crushed the Market This Week

Here's Why Grail Shares Crashed in February and Why it Could Be a Buying Opportunity

Here's Why Grail Stock Bounced Back 16% Today

Why Grail Shares Are Plummeting

Here's Why Grail Stock Slumped Again Today

This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50%

GRAL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Grail

GRAL Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Grail Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GRAL

What is the current price of Grail?

What is the 52-week range for Grail?

How much debt does Grail have?

How much cash does Grail have on hand?

What is Grail’s dividend yield?

Premium Investing Services